Answers are grounded in this paper and cite their sources.
Advanced diagnostic imaging is now recognized as central to Heart Team decision-making for longitudinal management of valvular heart disease in the 2025 ESC/EACTS guidelines.
The 2025 ESC/EACTS Guidelines on valvular heart disease arrive at a moment when ‘treatment direction’ is no longer a single choice between surgery and catheter therapy but a longitudinal strategy—indexed to lifetime risk, feasibility of repeat procedures, and the real (often competing) priorities of patients. In that landscape, imaging is not simply diagnostic: it is the language that allows the Heart Team to translate anatomy, haemo-dynamics, symptoms, comorbidity, and procedural risk into a coherent plan. The guideline update explicitly reinforces this centrality—linking Heart Team decision-making, Heart Valve Centres, and ‘advanced diagnostic imaging with more clearly defined
No takes yet. Share an insight, caveat, or question.
Zancanaro et al. (2026) conducted an editorial in Valvular heart disease. Advanced diagnostic imaging was evaluated. The 2025 ESC/EACTS Guidelines on valvular heart disease reinforce the centrality of advanced diagnostic imaging in guiding longitudinal treatment strategies and Heart Team decision-making.
Synapse has enriched 10 related papers. Consider them for comparative context: